{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:07:56Z","timestamp":1767834476239,"version":"3.49.0"},"reference-count":59,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T00:00:00Z","timestamp":1203292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evaluation Clinical Practice"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Rationale, aims and objectives\u2002<\/jats:bold> This study is part of a research effort to identify and quantify factors related to the cost\u2010effectiveness of a vaccine acquisition strategy to reduce the burden of infectious diarrhoea on US military personnel deployed overseas. Where evidence is lacking in the scientific literature, or considerable uncertainty exists, it is often necessary to develop best estimates with ranges of certainty. To this end, a modified \u2018Delphi\u2019 survey technique to obtain the best estimates for uncertain parameters including clinical care\u2010seeking behaviour for acute diarrhoea, routine diarrhoea management in a deployed setting, and vaccine development time frames and costs were developed from a diverse panel of experts.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> The study was conducted in three survey iterations. During each iteration, participants were contacted and given 2\u20133\u2003weeks to complete a web\u2010based survey designed to ascertain estimates, ranges of variability, and level of certainty for these estimates.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> In all, 25 of 43 solicited experts agreed to participate in the study. These included three (12%) experts who identified themselves primarily as being currently involved in Vaccine Industry, six (24%) Academic\/Military Diarrheal Vaccine Development, five (20%) Military Product Acquisition, five (20%) Military Preventive Medicine, two (8%) Tropical\/Travel Medicine and four (16%) Military Clinical Infectious Disease. Management practices in deployed military populations (for both provider and self\u2010treatment) were consistent with recently published literature. Similar target time frames for vaccine licensure were established for Enterotoxigenic <jats:italic>E.\u2003coli<\/jats:italic>, <jats:italic>Campylobacter<\/jats:italic>, <jats:italic>Shigella<\/jats:italic> and Norovirus of around 9\u201311\u2003years. Targets for vaccine efficacy appear to be lower than currently licensed travel vaccines (60\u201380%), and there was consensus on more conservative adverse event rates.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> These data should prove useful to researchers and policy makers working in the area of vaccine acquisition for the US military and provide continued information on the gap in optimal travellers\u2019 diarrhoea management practices in a deployed setting.<\/jats:p>","DOI":"10.1111\/j.1365-2753.2007.00848.x","type":"journal-article","created":{"date-parts":[[2008,2,18]],"date-time":"2008-02-18T13:31:21Z","timestamp":1203341481000},"page":"266-274","source":"Crossref","is-referenced-by-count":10,"title":["Reaching a consensus on management practices and vaccine development targets for mitigation of infectious diarrhoea among deployed US military forces"],"prefix":"10.1111","volume":"14","author":[{"given":"Mark S.","family":"Riddle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Tribble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,18]]},"reference":[{"issue":"5","key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4269\/ajtmh.2006.74.891","article-title":"Incidence, etiology, and impact of diarrhea among long\u2010term travelers (US military and similar populations): a systematic review","volume":"74","author":"Riddle M. S.","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"e_1_2_5_3_2","first-page":"9","article-title":"Military importance of diarrhea: lessons from the Middle East","volume":"21","author":"Sanders J. W.","year":"2005","journal-title":"Current Opinions in Gastroenterology"},{"issue":"4","key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4269\/ajtmh.2005.73.713","article-title":"Impact of illness and non\u2010combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan)","volume":"73","author":"Sanders J. W.","year":"2005","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.06.008"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2571-2572.2005"},{"key":"e_1_2_5_7_2","volume-title":"Institute of Medicine Report \u2018Vaccines for the 21st century","author":"The National Vaccines Advisory Committee (NVAC)","year":"2005"},{"key":"e_1_2_5_8_2","volume-title":"Protecting Our Forces: Improving Vaccine Acquisition and Availability in the US Military. IOM Report","author":"Lemon S. M.","year":"2003"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.02.005"},{"key":"e_1_2_5_10_2","volume-title":"Azithromycin and Loperamide Is Comparable to Levofloxacin and Loperamide for the Treatment of Traveler\u2019s Diarrhea in U.S. Military Personnel in Turkey.","author":"Sanders J. W.","year":"2005"},{"issue":"6","key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7205\/MILMED.170.6.492","article-title":"Knowledge, attitudes, and practices regarding epidemiology and management of travelers\u2019 diarrhea: a survey of front\u2010line providers in Iraq and Afghanistan","volume":"170","author":"Riddle M. S.","year":"2005","journal-title":"Military Medicine"},{"issue":"5","key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.67.533","article-title":"An observational clinic\u2010based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection","volume":"67","author":"Sanders J. W.","year":"2002","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4269\/ajtmh.1998.58.299","article-title":"Diarrheal disease incidence and morbidity among United States military personnel during short\u2010term missions overseas","volume":"58","author":"Sanchez J. L.","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.5.868"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111143252006"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.7748\/ns1999.07.13.45.32.c2650"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8305.2006.00020.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.10.014"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.spid.2004.07.009"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.2310\/7060.2000.00007"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.2.1062-1071.2006"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00613-8"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.1874-1880.2002"},{"issue":"2","key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4269\/ajtmh.2001.65.120","article-title":"Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia","volume":"65","author":"Oyofo B. A.","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JCM.38.1.27-31.2000","article-title":"Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2\u2010year period from diarrheal patients in Bangladesh","volume":"38","author":"Qadri F.","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/338834"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.014"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000078156.03697.a5"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1351-1357.2001"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.7.4545-4553.2001"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.8.2.107"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/513791"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)06255-1"},{"issue":"10","key":"e_1_2_5_35_2","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/iai.64.10.4074-4077.1996","article-title":"Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers","volume":"64","author":"Cohen D.","year":"1996","journal-title":"Infection and Immunity"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.2.923-930.2004"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.2016-2021.2002"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1034-1039.2000"},{"issue":"11","key":"e_1_2_5_39_2","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1128\/iai.64.11.4542-4548.1996","article-title":"Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG","volume":"64","author":"Kotloff K. L.","year":"1996","journal-title":"Infection and Immunity"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.5.1068"},{"issue":"2","key":"e_1_2_5_41_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jcm.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen D.","year":"1991","journal-title":"Journal of Clinical Microbiology"},{"issue":"11","key":"e_1_2_5_42_2","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/iai.59.11.4075-4083.1991","article-title":"Small\u2010animal model to measure efficacy and immunogenicity of Shigella vaccine strains","volume":"59","author":"Hartman A. B.","year":"1991","journal-title":"Infection and Immunity"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.2950-2958.2002"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6616(03)00120-7"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1086\/315653"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70548-2"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.1.18"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm860"},{"key":"e_1_2_5_49_2","unstructured":"Centers for Disease Control and Prevention. (2005)Health Information for International Travel 2005\u20132006. Atlanta:US Department of Health and Human Services Public Health Service."},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2004.11.004"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70277-4"},{"issue":"10","key":"e_1_2_5_52_2","first-page":"376","article-title":"Adverse events after oral vaccination against cholera with CVD103\u2010HgR","volume":"110","author":"Wiedermann G.","year":"1998","journal-title":"Wiener Klinische Wochenschrift"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7125.110"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(96)91281-5"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7001.376"},{"issue":"11","key":"e_1_2_5_56_2","first-page":"76","article-title":"Cost\u2010effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers","volume":"49","author":"Sibbald R. G.","year":"2003","journal-title":"Ostomy\/Wound Management"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(01)00115-4"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0300-9475.2002.01036.x"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(96)00630-4"},{"key":"e_1_2_5_60_2","unstructured":"StrattonK. R. Durch J. S.&Lawrence R. S.(1999)Vaccines for the 21st Century: A Tool for Decision Making. IOM Report. Washington DC:Institute of Medicine National Academies."}],"container-title":["Journal of Evaluation in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2753.2007.00848.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2753.2007.00848.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:58:53Z","timestamp":1697165933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2753.2007.00848.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,18]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1365-2753.2007.00848.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2753.2007.00848.x","archive":["Portico"],"relation":{},"ISSN":["1356-1294","1365-2753"],"issn-type":[{"value":"1356-1294","type":"print"},{"value":"1365-2753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,18]]}}}